drugset / Trial / NCT00817089

Understanding Treatment Response With Naltrexone Among White Alcoholics

NCT00817089

Phase 4 Completed 24 enrolled University of Pennsylvania
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study involving treatment for alcohol dependence among males of European or Asian decent. The ultimate aim of this line of investigation is to further establish a genetic link between alcohol dependence and treatment by defining an endophenotype associated with treatment response. The study consists of two inpatient alcohol challenge sessions with treatment using random assignment to either naltrexone or placebo.

Timeline

Start
2007-12
Primary completion
2010-04
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule 50 mg

Indications